{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:04:35Z","timestamp":1791216275578,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"vor","delay-in-days":3078,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.jtcvs.2007.08.047","type":"journal-article","created":{"date-parts":[[2008,2,2]],"date-time":"2008-02-02T07:18:58Z","timestamp":1201936738000},"page":"389-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Recent advances in understanding Marfan syndrome: Should we now treat surgical patients with losartan?"],"prefix":"10.25013","volume":"135","author":[{"given":"Peter","family":"Matt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Habashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Carrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duke E.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Van Eyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry C.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2007.08.047_bib1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan\u2019s syndrome","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJM197204132861502","article-title":"Life expectancy and causes of death in the Marfan syndrome","volume":"286","author":"Murdoch","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.athoracsur.2006.03.073","article-title":"Valve-sparing aortic root replacement: early experience with the De Paulis Valsalva graft in 51 patients","volume":"82","author":"Patel","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan\u2019s syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","volume":"114","author":"Judge","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states","volume":"13","author":"Cohn","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/geno.1998.5697","article-title":"Revised genomic organization of FBN1 and significance for regulated gene expression","volume":"56","author":"Biery","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0959-437X(96)80007-4","article-title":"Fibrillin mutations in Marfan syndrome and related phenotypes","volume":"6","author":"Ramirez","year":"1996","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/humu.10249","article-title":"Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database","volume":"22","author":"Collod-Beroud","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0945-053X(00)00101-3","article-title":"Mouse models of genetic diseases resulting from mutations in elastic fiber proteins","volume":"19","author":"Dietz","year":"2000","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physiolgenomics.00092.2004","article-title":"Fibrillin microfibrils: multipurpose extracellular networks in organismal physiology","volume":"19","author":"Ramirez","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib15","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","article-title":"Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1","volume":"96","author":"Pereira","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0070-2153(04)62006-0","article-title":"Vascular extracellular matrix and aortic development","volume":"62","author":"Kelleher","year":"2004","journal-title":"Curr Top Dev Biol"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.RES.88.1.37","article-title":"Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome","volume":"88","author":"Bunton","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib18","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/CIRCULATIONAHA.105.601674","article-title":"Induction of macrophage chemotaxis by aortic extracts of the mgR Marfan mouse model and a GxxPG-containing fibrillin-1 fragment","volume":"114","author":"Guo","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib19","first-page":"II331","article-title":"Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan\u2019s syndrome","volume":"98","author":"Segura","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00439-007-0371-x","article-title":"Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome","volume":"122","author":"Matyas","year":"2007","journal-title":"Hum Genet"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib21","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/hmg\/ddg241","article-title":"Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?","volume":"12","author":"Hutchinson","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib22","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/hmg\/2.10.1762","article-title":"Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome","volume":"2","author":"Pereira","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib23","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI200422715","article-title":"TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome","volume":"114","author":"Ng","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib25","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/01.hjh.0000182521.44440.c5","article-title":"Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats","volume":"23","author":"Lavoie","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.HYP.23.5.587","article-title":"Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression","volume":"23","author":"Everett","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0895-7061(00)00298-3","article-title":"Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR","volume":"13","author":"Kubo","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0704331","article-title":"Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis","volume":"134","author":"Daugherty","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib29","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0002-9149(99)00101-0","article-title":"Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome","volume":"83","author":"Rossi-Foulkes","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1511","article-title":"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2","volume":"37","author":"Loeys","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtcvs.2007.08.047_bib31","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/humu.20353","article-title":"Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders","volume":"27","author":"Matyas","year":"2006","journal-title":"Hum Mutat"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522307015462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522307015462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:43:25Z","timestamp":1758386605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522307015462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0022522307015462"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2007.08.047","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in understanding Marfan syndrome: Should we now treat surgical patients with losartan?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2007.08.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}